HomeCompareKDGTF vs PLD

KDGTF vs PLD: Dividend Comparison 2026

KDGTF yields 292.70% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KDGTF wins by $1277.63M in total portfolio value
10 years
KDGTF
KDGTF
● Live price
292.70%
Share price
$0.68
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1283.54M
Annual income
$767,632,391.00
Full KDGTF calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — KDGTF vs PLD

📍 KDGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKDGTFPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KDGTF + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KDGTF pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KDGTF
Annual income on $10K today (after 15% tax)
$24,879.26/yr
After 10yr DRIP, annual income (after tax)
$652,487,532.35/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, KDGTF beats the other by $648,449,415.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KDGTF + PLD for your $10,000?

KDGTF: 50%PLD: 50%
100% PLD50/50100% KDGTF
Portfolio after 10yr
$644.72M
Annual income
$386,191,558.09/yr
Blended yield
59.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

KDGTF
No analyst data
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KDGTF buys
0
PLD buys
0
No recent congressional trades found for KDGTF or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKDGTFPLD
Forward yield292.70%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$1283.54M$5.91M
Annual income after 10y$767,632,391.00$4,750,725.19
Total dividends collected$1231.38M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: KDGTF vs PLD ($10,000, DRIP)

YearKDGTF PortfolioKDGTF Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$39,970$29,269.72$11,241$540.96+$28.7KKDGTF
2$152,104$109,336.69$13,019$991.13+$139.1KKDGTF
3$551,611$388,859.29$15,801$1,870.97+$535.8KKDGTF
4$1,908,177$1,317,953.42$20,609$3,701.21+$1.89MKDGTF
5$6,302,657$4,260,907.77$29,919$7,867.97+$6.27MKDGTF
6$19,896,799$13,152,956.21$50,631$18,617.74+$19.85MKDGTF
7$60,095,598$38,806,022.48$105,528$51,352.20+$59.99MKDGTF
8$173,842,808$109,540,518.26$287,364$174,449.42+$173.56MKDGTF
9$482,157,266$296,145,461.77$1,081,760$774,280.77+$481.08MKDGTF
10$1,283,540,666$767,632,391.00$5,908,209$4,750,725.19+$1277.63MKDGTF

KDGTF vs PLD: Complete Analysis 2026

KDGTFStock

Kindstar Globalgene Technology, Inc. provides esoteric testing services to hospitals in China. The company offers its esoteric testing services for clinical specialist physicians in hematologic tumor, rare diseases, diseases of obstetrics and gynecology, neurology, infectious diseases, solid tumors, etc. It provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules and evaluation for curative effect of specialized diseases. The company's lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and other esoteric testing laboratories. The company was founded in 2003 and is headquartered in in Wuhan, China.

Full KDGTF Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this KDGTF vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KDGTF vs SCHDKDGTF vs JEPIKDGTF vs OKDGTF vs KOKDGTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.